Literature DB >> 7391588

Simultaneous preparation of mononuclear and polymorphonuclear leucocytes from horse blood on Ficoll-Hypaque medium.

A Ferrante, Y H Thong.   

Abstract

Results presented show that highly purified populations of mononuclear (MN) and polymorphonuclear (PMN) leucocytes can be obtained from horse blood by a procedure similar to that previously described for the separation of these leucocytes from human blood. This involved centrifugation of horse blood on a Ficoll-Hypaque medium with a density of 1.095 g/ml. The procedure required approximately 1 h for completion and resulted in the simultaneous preparation of MN (greater than 98% purity) and PMN (greater than 96% purity) leucocytes. Cell viability exceeded 95% and cells retained immunological functions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391588     DOI: 10.1016/0022-1759(80)90100-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu.

Authors:  Landon W Locke; Mahendra D Chordia; Yi Zhang; Bijoy Kundu; Dylan Kennedy; Jessica Landseadel; Li Xiao; Karen D Fairchild; Stuart S Berr; Joel Linden; Dongfeng Pan
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

2.  Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis.

Authors:  D Zhu; C F Cheng; B U Pauli
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Chlorinated lipid species in activated human neutrophils: lipid metabolites of 2-chlorohexadecanal.

Authors:  Dhanalakshmi S Anbukumar; Laurie P Shornick; Carolyn J Albert; Melissa M Steward; Raphael A Zoeller; William L Neumann; David A Ford
Journal:  J Lipid Res       Date:  2009-12-17       Impact factor: 5.922

4.  Rapid single-step method for purification of polymorphonuclear leucocytes from blood of patients with rheumatoid arthritis.

Authors:  A Ferrante; D W James; W H Betts; L G Cleland
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.